Home > Clinical Trials
Check All Search

Saved trials

ACTIVE_NOT_RECRUITING
NCT03568890
Short-Term Anticoagulation Versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure
510 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Left Atrial Appendage Closure


Thrombosis


Stroke


TIA


Bleeding
ACTIVE_NOT_RECRUITING
NCT05246514
A Single Arm Phase 2 Study to Evaluate Efficacy and Safety of Trastuzumab Deruxtecan for Patients With HER2 Mutant NSCLC
72 Enrollment(s)
28 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-mutant Non-Small Cell Lung Cancer
ACTIVE_NOT_RECRUITING
NCT05660135
Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
4,000 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hypertension


Dyslipidemias
ACTIVE_NOT_RECRUITING
NCT05411887
Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
2,845 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Hyperlipidemias


Hypertension
NOT_YET_RECRUITING
NCT07116239
Edoxaban Steady-State PK/PD in Adults With Nephrotic Syndrome
60 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (NA)
Nephrotic Syndrome


Hypoalbuminemia
RECRUITING
NCT06494111
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
295 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Lymphedema


Fibrosis
RECRUITING
NCT05491200
Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
1,656 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
ST Elevated Myocardial Infarction


Dual Antiplatelet Therapy
COMPLETED
NCT04284657
Pravastatin and Alkali Therapy in Patients With Autosomal Dominant Polycystic Kidney Disease
1 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
Autosomal Dominant Polycystic Kidney Disease